YOLFTbeta
Geninus Inc.

Geninus Inc.

389030 · KQ · Healthcare / Biotechnology

1,368.00KRW+9.00 (+0.66%)

Price History

Full chart

Market Stats

Previous Close1,359.00
Open1,359.00
Day Range1,342.00 – 1,478.00
52-Week Range1,610.00 – 6,480.00
Volume491.26K
Market Cap82.01B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta0.14
50-Day Avg2,021.20
200-Day Avg3,334.58

About

GENINUS Inc., a bioinformation analysis company, engages in the research and development, manufacture, and sale of genome analysis solutions in South Korea, the United States, and Asia. It offers tarhet and biomarker discovery; AI digital pathology; single cell analysis; and spatial and in-situ transcriptomics services; and SPACEINSIGHT, a cutting-edge cloud based integrated analysis platform. It serves hospitals, pharmaceutical companies, and researchers. The company was founded in 2018 and is headquartered in Seoul, South Korea.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOMr. Woongyang Park M.D., Ph.D.
  • Employees62
  • HeadquartersKDU Tower, Seoul, South Korea, 05836, Korea
  • Websitehttps://kr-geninus.com

Leadership

  • Mr. Woongyang Park M.D., Ph.D.Chief Executive Officer
  • Mr. Wansung KuChief Financial Officer
  • Mr. Yongju BangChief Operating Officer

Financials

Income Statement

Currency: KRW2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue01.38B3.79B8.13B10.08B6.97B6.46B10.48B
Growth (%)--+175.81%+114.37%+23.96%-30.90%-7.35%+62.40%
Cost of Revenue01.64B2.42B7.11B9.23B6.88B6.37B10.31B
Gross Profit0-266.36M1.37B1.03B849.17M83.21M81.14M173.02M
Gross Margin--19.36%36.20%12.61%8.42%1.19%1.26%1.65%
Operating Expense296.45M1.15B5.14B8.65B10.53B10.18B12.37B11.84B
Operating Income-296.45M-1.42B-3.77B-7.62B-9.68B-10.10B-12.29B-11.67B
Operating Margin--102.90%-99.23%-93.69%-96.03%-144.91%-190.37%-111.33%
EBITDA-----7.78B-7.53B-9.41B-13.50B
EBITDA Margin-----77.14%-108.04%-145.72%-128.79%
Net Income-309.49M-3.09B-9.15B-9.02B-9.38B-9.68B-12.27B-17.37B
Net Income Margin--224.89%-241.19%-110.88%-93.07%-139.00%-190.12%-165.72%
R&D--3.13B4.31B5.33B2.20B2.19B3.07B
R&D as % of Total Revenue--82.59%52.94%52.83%31.62%33.99%29.25%
Interest Expense001.04B1.09B8.34M47.08M154.36M630.05M
Interest Expense % of Total Revenue-0.00%27.47%13.38%0.08%0.68%2.39%6.01%

Balance Sheet

Currency: KRW2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets3.34B12.98B30.40B58.06B45.83B40.53B33.09B39.35B
Total Liabilities2.49B15.20B41.62B6.16B2.56B6.04B10.85B30.25B
Total Equity852.61M-2.22B-11.22B51.91B43.27B34.49B22.24B9.10B
Cash132.00K117.00K3.19M44.85B22.75B11.83B5.24B6.62B
Total Debt41.74M3.35B3.30B-----
Net Debt-299.97M-----1.36B

Cash Flow

Currency: KRW2018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow61.58M-2.35B1.84B-9.29B-11.94B-8.13B-10.67B-7.08B
Investing Cash Flow-877.00M-7.73B-11.96B10.70B-9.90B-3.74B-120.96M-
Financing Cash Flow2.22B11.75B15.74B34.74B-261.30M991.07M4.20B-
Capital Expenditure1.60B4.83B1.88B1.64B2.06B3.29B3.13B1.38B
Free Cash Flow---37.70M-11.33B-14.00B-11.41B-13.80B-8.46B
FCF to OCF---2.05%121.96%117.26%140.44%129.30%119.48%

Earnings

Report DateDec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-------------------
EPS Actual-92.85-62.74-87.39-28.00-110.10-72.08-42.50-77.91-101.13-84.28-117.53-59.87-106.66-70.95-132.64-73.43-243.88-60.66-215.00
Surprise-------------------
Timing-------------------

Key Statistics & Ratios

Market Cap82.01B
Enterprise Value56.04B
Trailing P/E0.00
Forward P/E0.00
Price / Sales7.27
Price / Book2.02
Revenue (TTM)11.28B
Gross Profit (TTM)259.43M
EBITDA-8.83B
Profit Margin-180.50%
Operating Margin-127.39%
Return on Equity-72.44%
Return on Assets-16.15%
Shares Outstanding39.24M
Shares Float21.21M
Beta0.14
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Jul 13, 20223:1